Evidence map›Paper›PMID 40418649›Full record

ReviewHuman vaccines & immunotherapeutics2025

How has the field of immunogenic cell death in breast cancer evolved and impacted clinical practice over the past eleven years?

Yu-Long Deng, Bang-Teng Chi, Shang-Yi Lu, Dan-Dan Xiong, Rong-Quan He, Di-Yuan Qin, Wan-Ying Huang, Xia Yang, Gang Chen, Wei Peng and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yu-Long DengDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China.ORCID 0009-0005-5314-2576
Bang-Teng ChiDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China.ORCID 0009-0000-5504-5589
Shang-Yi LuDepartment of Hepatological and Gland Surgery, Wuzhou Gongren Hospital/The Seventh Affiliated Hospital of Guangxi Medical University, Wuzhou, P. R. China.ORCID 0009-0004-4867-0908
Dan-Dan XiongDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China.ORCID 0000-0002-5362-0938
Rong-Quan HeDepartment of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China.ORCID 0000-0002-7752-2080
Di-Yuan QinDepartment of Computer Science and Technology, School of Computer and Electronic Information, Guangxi University, Nanning, P. R. China.ORCID 0009-0003-3214-4762
Wan-Ying HuangDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China.ORCID 0000-0002-8314-5963
Xia YangDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China.ORCID 0009-0008-8590-8734
Gang ChenDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China.ORCID 0000-0003-2402-2987
Wei PengDepartment of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China.ORCID 0009-0007-3492-0875
Jiayuan LuoDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China.ORCID 0000-0003-4712-5217

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study elucidates the research landscape of immunogenic cell death (ICD) in breast cancer through a bibliometric analysis of 457 Web of Science articles. Contributions from China and the USA are particularly prominent, with notable international collaborations. Core journals such as

Indexed as

Breast NeoplasmsImmunogenic Cell DeathImmunotherapyBibliometricsFemaleHumansNanomedicinePhotochemotherapyTriple Negative Breast NeoplasmsTumor MicroenvironmentbibliometricBreast cancerclinical practiceimmunogenic cell deathimmunotherapy

Identifiers

PMID40418649
PMCPMC12118423

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.